Picture of Repligen logo

RGEN — Repligen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Repligen Corp reports results for the quarter ended in December - Earnings Summary

* Repligen Corp  RGEN.OQ  reported quarterly adjusted
earnings of
68 cents​​ per share for the quarter ended in December. The mean
expectation of eleven analysts for the quarter was for earnings
of 58 cents per share.
    * Revenue rose 0.1% to $186.76 million from a year ago;
analysts
expected $184.56 million. 
    * Repligen Corp's reported EPS for the quarter was 85
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * Repligen Corp shares had risen by 5.1% this quarter.
    * The company reported quarterly net income of $48.73
million.
    * Wall Street's median 12-month price target for Repligen
Corp is
$230.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
22 at 02:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.58           0.68           Beat
 Sep. 30 2022      0.68           0.77           Beat
 Jun. 30 2022      0.72           0.91           Beat
 Mar. 31 2022      0.72           0.92           Beat

Recent news on Repligen

See all news